The RM Partners Medicines Optimisation group is hosting the second pan-London education evening on Wednesday 16 January 2019, with a focus on ‘ESMO Highlights’. The …
Read moreAuthor Archives: Ricki Ostrov
Bowel screening reminder service a success
The RM Partners pilot to increase uptake bowel screening across south west London has proven incredibly successful. All six CCGs in the area took part, …
Read moreCelebrating our impact and achievements
The RM Partners Annual Review, which celebrates our transformational cancer work across west London, has now been published. The review contains a number of examples …
Read moreLung health checks benefitting hundreds of west Londoners
Over 500 people in Hillingdon and Hammersmith and Fulham have already participated in the RM Partners pilot project to help pick up lung cancer earlier. …
Read moreRAPID wins HSJ award for innovation
Our RAPID (Rapid Access to Prostate Imaging and Diagnosis) project won the prestigious HSJ Award for Acute …
Read moreSocial media campaign to increase cervical screening uptake
RM Partners, in partnership with the Hammersmith and Fulham GP Federation, is running a social media campaign to raise awareness of a new service encouraging …
Read moreHelping GPs improve skin cancer diagnoses in Sutton
RM Partners is supporting a small pilot project in Sutton to help GPs learn to better identify suspicious skin lesions and increase appropriate referrals. Working …
Read moreSharing learning about our RAPID prostate pathway
RM Partners held the first RAPID prostate pathway network meeting to share data, look at the similarities and differences of the three pilot pathways, and …
Read moreAI helping GPs identify possible cancers earlier
RM Partners has just launched a pilot in Sutton that uses an award winning AI decision support tool, C the Signs, to help GPs identify …
Read moreNew patient information leaflet on biosimilar trastuzumab
The second cancer biosimilar, trastuzumab, has been approved to treat patients with HER2-positive early breast cancer, metastatic breast cancer, and metastatic gastric cancer. Biosimilar trastuzumab …
Read more